[featured_image]
  • Version
  • Download
  • File Size 0.00 KB
  • File Count 1
  • Create Date May 16, 2024
  • Last Updated May 16, 2024

Modified Lung Immune Predictive Index (mLIPI) as a predictive tool of nivolumab outcomes and immune related adverse events in advanced non-small cell lung cancer (NSCLC) patients, Ken O'Byrne

Ken Bryne presents data on a Modified Lung Immune Predictive Index (mLIPI) as a predictive tool of nivolumab outcomes and immune related adverse events in advanced non-small cell lung cancer (NSCLC) at the 2019 BTOG annual conference

Attached Files

FileAction
wp-Download